论文部分内容阅读
目的:观察慢性心力衰竭(chf)合并室性早搏患者在常规治疗的基础上加用芪苈强心胶囊联合参松养心胶囊的疗效。方法:76例chf患者随机分为2组,治疗组(50例):在控制感染、治疗原发病及伴发疾病等常规治疗的基础上加用芪苈强心胶囊1.2g口服,每日3次,参松养心胶囊,每次4粒,3次/d,对照组(26例);均3周后统计疗效。结果:治疗组治疗后临床总有效率、部分心功能指标、室性早搏消失情况均好于对照组(P<0.05,P<0.01)。结论:芪苈强心胶囊与参松养心胶囊联合应用治疗慢性心力衰竭合并室性早搏的效果明显,且不良反应较少。
Objective: To observe the curative effect of Qili Qiangxin Capsule and Shensong Yangxin Capsule on the basis of routine treatment in patients with chronic heart failure (chf) complicated with premature ventricular contractions. Methods: Seventy-six patients with chf were randomly divided into two groups. The treatment group (50 cases) received daily qiqiangqinxin capsule 1.2g on the basis of conventional treatment of infection, treatment of primary disease and concomitant disease, 3 times, Shensongyangxin capsules, each 4, 3 times / d, the control group (26 cases); 3 weeks after the statistical effect. Results: After treatment, the clinical total effective rate, some cardiac function indexes and the disappearance of ventricular premature beats in the treatment group were better than those in the control group (P <0.05, P <0.01). Conclusion: The combination of Qili Qiangxin Capsule and Shensong Yangxin Capsule in treating chronic heart failure complicated with ventricular premature beats has obvious effect with few adverse reactions.